has been cited by the following article(s):
|
[1]
|
Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study
International Journal of Colorectal Disease,
2026
DOI:10.1007/s00384-025-05057-8
|
|
|
|
|
[2]
|
Severe intracranial infectious complication after sclerotherapy in facial venous malformations: a case report
International Journal of Emergency Medicine,
2026
DOI:10.1186/s12245-026-01177-2
|
|
|
|
|
[3]
|
Polidocanol Foam Sclerotherapy for Nodular Type V Port‐Wine Birthmark: A Retrospective Study
Dermatologic Therapy,
2026
DOI:10.1155/dth/7303162
|
|
|
|
|
[4]
|
Evaluating the Non-conventional Achalasia Treatment Modalities
Frontiers in Medicine,
2022
DOI:10.3389/fmed.2022.941464
|
|
|
|
|
[5]
|
Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
Techniques in Coloproctology,
2022
DOI:10.1007/s10151-022-02600-5
|
|
|
|
|
[6]
|
Adjuvant radiofrequency thermocoagulation improves the outcome of liquid sclerotherapy in the treatment of spider veins of the leg: A pilot study
Phlebology: The Journal of Venous Disease,
2021
DOI:10.1177/02683555211006534
|
|
|
|
|
[7]
|
Foam‐in‐vein: A review of rheological properties and characterization methods for optimization of sclerosing foams
Journal of Biomedical Materials Research Part B: Applied Biomaterials,
2020
DOI:10.1002/jbm.b.34681
|
|
|
|